At the 91st Annual Shareholder Meeting of Vifor Pharma Ltd., shareholders approved the election of Dr. Sue Mahony and Kim Stratton as new members of Board of Directors. Daniela Bosshardt-Hengartner, Dr. Sylvie Grégoire, and Fritz Hirsbrunner did not stand for re-election. The following members of the Board of Directors were elected to the Remuneration Committee for a term of one year: Prof. Dr. Michel Burnier, Dr. Romeo Cerutti, and Dr. Sue Mahony. The Committee will be chaired by Dr. Sue Mahony.

A dividend of CHF 2.00, as proposed by the Board of Directors, was approved and will be paid to shareholders on 14 May 2019.